{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:34Z","timestamp":1790916814641,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":180,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101306","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:43:23Z","timestamp":1784904203000},"page":"101306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune checkpoint inhibitor (ICI) associated corneal allograft rejection"],"prefix":"10.1016","volume":"48","author":[{"given":"Philip","family":"Marjon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Echegoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Schanzlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0367-3270","authenticated-orcid":false,"given":"Edward F.","family":"McClay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101306_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101852","article-title":"Local T cell infiltrates are predominantly associated with corneal allograft rejection","volume":"79","author":"Sakowska","year":"2023","journal-title":"Transpl. Immunol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101306_bib0002","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","article-title":"Management of high-risk corneal transplantation","volume":"62","author":"Di Zazzo","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2147\/OPTH.S398418","article-title":"Risk factors for descemet membrane endothelial keratoplasty rejection: current perspectives- systematic review","volume":"Volume 17","author":"Gurnani","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2016.10.008","article-title":"Corneal graft rejection in a patient treated with nivolumab for primary lung cancer","volume":"102","author":"Le Fournis","year":"2016","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101306_bib0005","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/ICO.0000000000002372","article-title":"Bilateral corneal graft rejection associated with Pembrolizumab treatment","volume":"39","author":"Vanhonsebrouck","year":"2020","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101306_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CJI.0000000000000536","article-title":"Corneal transplant rejection following durvalumab therapy in a patient with NSCLC: a case report","volume":"48","author":"Froessl","year":"2025","journal-title":"J. Immunother"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101306_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and Nivolumab versus Nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101306_bib0008","first-page":"10","article-title":"Role of immune cell diversity and heterogeneity in corneal graft survival: a systematic review and meta-analysis","author":"Zhu","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101306_bib0009","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ico.0000214230.21238.3d","article-title":"Absence of blood and lymphatic vessels in the developing Human cornea","volume":"25","author":"Cursiefen","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ctarc.2026.101306_bib0010","doi-asserted-by":"crossref","DOI":"10.4137\/OED.S2813","article-title":"Stratification of antigen-presenting cells within the normal cornea","volume":"1","author":"Knickelbein","year":"2009","journal-title":"Ophthalmol. Eye Dis."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101306_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtos.2014.10.003","article-title":"Barrier function in the ocular surface: from conventional paradigms to new opportunities","volume":"13","author":"Leong","year":"2015","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101306_bib0012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1167\/iovs.02-0838","article-title":"The corneal stroma is endowed with a significant number of resident dendritic cells","volume":"44","author":"Hamrah","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ctarc.2026.101306_bib0013","article-title":"Molecular characteristics and distribution of adult Human corneal immune cell types","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol."},{"issue":"31","key":"10.1016\/j.ctarc.2026.101306_bib0014","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217795120","article-title":"Redefining the human corneal immune compartment using dynamic intravital imaging","volume":"120","author":"Downie","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101306_bib0015","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3390\/ijms21113962","article-title":"Immune checkpoints contribute corneal Immune privilege: implications for dry eye associated with checkpoint inhibitors","volume":"21","author":"Hori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101306_bib0016","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101306_bib0017","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/mi.2014.127","article-title":"Suppression of toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC1 and MUC16","volume":"8","author":"Menon","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0018","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2025.1602877","article-title":"Regulation of the immune microenvironment and immunotherapy after liver transplantation","volume":"16","author":"Lan","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0019","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3389\/fimmu.2021.535012","article-title":"Clinical and basic research progress on treg-induced immune tolerance in liver transplantation","volume":"12","author":"Ni","year":"2021","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101306_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/cmi.2016.5","article-title":"Immunological functions of liver sinusoidal endothelial cells","volume":"13","author":"Knolle","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"Pt 2","key":"10.1016\/j.ctarc.2026.101306_bib0021","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1167975","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a review","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101306_bib0023","first-page":"322","article-title":"The evolving landscape of immunotoxicity: charting mechanisms and future strategies for immune checkpoint inhibitor adverse events","volume":"1","author":"Lin","year":"2025","journal-title":"Med. Res."},{"key":"10.1016\/j.ctarc.2026.101306_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2019.01.006","article-title":"Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis","volume":"64","author":"Kumar","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101306_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5415\/apallergy.0000000000000146","article-title":"From tumor to tolerance: a comprehensive review of immune checkpoint inhibitors and immune-related adverse events","volume":"14","author":"Sutanto","year":"2024","journal-title":"Asia Pac Allergy"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101306_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI96798","article-title":"Early B cell changes predict autoimmunity following combination immune checkpoint blockade","volume":"128","author":"Das","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101306_bib0027","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MOT.0000000000000772","article-title":"Precision transplant pathology","volume":"25","author":"Wood-Trageser","year":"2020","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101306_bib0028","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"Effectiveness of histocompatibility matching in high-risk corneal transplantation. The collaborative corneal transplantation studies research group","volume":"110","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101306_bib0029","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/cells13181532","article-title":"Immunopathology of corneal allograft rejection and donor-specific antibodies (DSAs) as immunological predictors of corneal transplant failure","volume":"13","author":"Olejkowska","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ctarc.2026.101306_bib0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2015.01.001","article-title":"Matching for Human leukocyte antigens (HLA) in corneal transplantation - to do or not to do","volume":"46","author":"van Essen","year":"2015","journal-title":"Prog. Retin Eye Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101306_bib0031","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5694\/mja12.11584","article-title":"The influence of Australian eye banking practices on corneal graft survival","volume":"199","author":"Keane","year":"2013","journal-title":"Med. J. Aust."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101306_bib0032","first-page":"137","article-title":"Studies on the nature of the privilege enjoyed by corneal allografts","volume":"11","author":"Khodadoust","year":"1972","journal-title":"Invest. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101306_bib0033","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101306_bib0034","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1002\/cam4.5394","article-title":"Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: a safety analysis from a literature review and a pharmacovigilance system","volume":"12","author":"Cui","year":"2023","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101306_bib0035","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ajt.2024.04.007","article-title":"Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: a multicenter, retrospective cohort study","volume":"24","author":"Guo","year":"2024","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101306_bib0036","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jhep.2024.06.042","article-title":"Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: a systematic review and individual patient data meta-analysis","volume":"82","author":"Rezaee-Zavareh","year":"2025","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101306_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101306_bib0038","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1159\/000510391","article-title":"Pediatric keratoplasty: the success of a tailor-made surgical management","volume":"11","author":"Nuzzi","year":"2020","journal-title":"Case Rep. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101306_bib0039","first-page":"1293","article-title":"The critical role of lymph nodes in corneal alloimmunization and graft rejection","volume":"42","author":"Yamagami","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101306_bib0040","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1600-6143.2008.02285.x","article-title":"Aqueous humor alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejection","volume":"8","author":"Flynn","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101306_bib0041","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.4049\/jimmunol.179.6.3672","article-title":"The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival","volume":"179","author":"Shen","year":"2007","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101306_bib0042","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1167\/iovs.05-1597","article-title":"Differential effects of costimulatory pathway modulation on corneal allograft survival","volume":"47","author":"Watson","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101306_bib0043","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.4049\/jimmunol.177.9.5928","article-title":"B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts","volume":"177","author":"Hori","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2026.101306_bib0044","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpba.2018.10.025","article-title":"Enzyme linked immunosorbent assay for the quantification of nivolumab and pembrolizumab in human serum and cerebrospinal fluid","volume":"164","author":"Pluim","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101306_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005132","article-title":"Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis","volume":"10","author":"Mallardo","year":"2022","journal-title":"J. Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101306_bib0046","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","article-title":"Advances in drug discovery based on network pharmacology and omics technology","volume":"21","author":"Liu","year":"2024","journal-title":"Curr. Pharm Anal."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:48Z","timestamp":1790913468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":46,"alternative-id":["S2468294226002170"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101306","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitor (ICI) associated corneal allograft rejection","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101306"}}